{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:46:21Z","timestamp":1789472781805,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/ckj\/sfx067","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T19:18:12Z","timestamp":1496431092000},"page":"560-563","source":"Crossref","is-referenced-by-count":8,"title":["Do we really need more evidence to use hepatitis C positive donor kidney more liberally?"],"prefix":"10.1093","volume":"10","author":[{"given":"Kiran","family":"Joglekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Eason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos Z.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"key\n\t\t\t\t20171012133917_sfx067-B1","first-page":"21","article-title":"OPTN\/SRTR 2015 annual data report: kidney","volume":"17 (Suppl 1)","year":"2017","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1681\/ASN.2015010023","article-title":"New solutions to reduce discard of kidneys donated for transplantation","volume":"27","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1600-6143.2010.03091.x","article-title":"Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B5","first-page":"564","article-title":"Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes","volume":"10","year":"2017","journal-title":"Clin Kindey J"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease","volume":"61","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B7","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/gfm205","article-title":"Hepatitis C virus: from entry to renal injury\u2013facts and potentials","volume":"22","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B8","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1681\/ASN.2005091006","article-title":"Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey","volume":"17","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00080.x","article-title":"Relationship between hepatitis C and microalbuminuria: results from the NHANES III","volume":"67","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","article-title":"Cell-mediated immunity and the outcome of hepatitis C virus infection","volume":"58","year":"2004","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jmv.20527","article-title":"Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact","volume":"78","year":"2006","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B12","first-page":"56","article-title":"Review article: an unexpected virus-host interaction\u2013the hepatitis C virus-diabetes link","volume":"22 (Suppl 2)","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","article-title":"Hepatitis C infection and chronic renal diseases","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/HMER.S63125","article-title":"Role of ledipasvir\/sofosbuvir combination for genotype 1 hepatitis C virus infection","volume":"8","year":"2016","journal-title":"Hepat Med"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.13518","article-title":"Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/tri.12799","article-title":"DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting","volume":"29","year":"2016","journal-title":"Transpl Int"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B19","doi-asserted-by":"crossref","first-page":"e0158431","DOI":"10.1371\/journal.pone.0158431","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B20","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/01.ASN.0000034944.90425.75","article-title":"Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation","volume":"13","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B21","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1600-6143.2004.00606.x","article-title":"The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B22","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.transproceed.2010.04.056","article-title":"Kidney grafts from HCV-positive donors: advantages and disadvantages","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","year":"2013","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7150\/ijms.8265","article-title":"Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients","volume":"11","year":"2014","journal-title":"Int J Med Sci"},{"key":"key\n\t\t\t\t20171012133917_sfx067-B25","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/10\/4\/560\/19377143\/sfx067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:59:22Z","timestamp":1507831162000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ckj\/article\/10\/4\/560\/3957956\/Do-we-really-need-more-evidence-to-use-hepatitis-C"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,12]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfx067","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,7,12]]}}}